We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Therefore, compound c2 is a promising candidate for further antifungal-based structure modification.
2
Intensive treatment with antifungal drugs was followed by remission of all symptoms.
3
The leading choice for mold-active agents for antifungal prophylaxis was the echinocandins.
4
Of the 12 antifungal saponins identified, two were selected for further analysis.
5
No fungal organisms were isolated from HIV-positive patients under antifungal drug treatment.
1
Treatment is hindered by the emergence of resistance to triazole antimycotic agents.
2
After initiation of antimycotic treatment the symptoms resolved completely.
3
The results of the antimicrobial assay showed that the presence of two amidic groups usually enhances antimycotic activity.
4
Our study demonstrates a variation of antimycotic and antifungal use in Europe, as striking as that of antibiotic use.
5
The progression of IFI despite antimycotic therapy illustrates the inherent problems of diagnosis and the need for innovative therapeutic modalities.
1
Intensive treatment with antifungaldrugs was followed by remission of all symptoms.
2
This unexpected finding provides a new tool for generating antifungaldrugs by biotransformation.
3
In contrast, antifungaldrugs belonging to other chemical classes did not display inhibitory activity.
4
These proteins might represent a potential target for the development of innovative antifungaldrugs.
5
This ex vivo study determined the extraction of antifungaldrugs by the ECMO circuit.
1
This study suggests that cranberry has potential as an antifungalagent.
2
This work validates HTA as an attractive drug-susceptible target for new antifungalagent design.
3
Infections were characterized by a chronic, indolent course requiring prolonged treatment with an antifungalagent.
4
Treatment consists in eradicating the causal fungus using an antifungalagent associated with symptomatic treatment.
5
Natamycin is a very attractive antifungalagent with wide applications in medical and food industries.
1
Broth microdilution-based susceptibility testing using six antifungalagents was also conducted.
2
This makes BPL an attractive drug target for new antifungalagents.
3
Furthermore, with widespread use of antifungalagents, drug-resistant fungal infections are on the rise.
4
It possesses several important features for development of antifungalagents.
5
In addition, the Company is engaged in the production of antibiotics and antifungalagents.
Usage of antifungal drug in English
1
No fungal organisms were isolated from HIV-positive patients under antifungaldrug treatment.
2
It's certainly worth giving them a try before taking a potent antifungaldrug.
3
However, there remains a paucity of antifungaldrug treatments available to combat these fungal pathogens.
4
Our studies provide insights into the yeast-host environment interaction and identify potential antifungaldrug targets.
5
The emergence of antifungaldrug resistance is inevitable.
6
These mutations add to a growing body of research on multiple antifungaldrug targets in this organism.
7
We conclude that an antifungaldrug directed against Fba1p would have to be potent to be effective.
8
Resistance to the antifungaldrug 5-fluorocytosine was not deleterious and appeared to be slightly advantageous in vivo.
9
The emergence of antifungaldrug resistance is an evolutionary process that proceeds on temporal, spatial, and genomic scales.
10
The combined effect of the most potent compound and an antifungaldrug miconazole was investigated using the checkerboard assay.
11
Thus, the present findings support additional studies for antifungaldrug development based on plant isolated-scopoletin to treat candidiasis caused by C. tropicalis.
12
We examined the feasibility of using whole genome sequencing (WGS) for genome-wide analysis of antifungaldrug resistance in C. glabrata.
13
Although numerous studies have assessed the effectiveness of antifungaldrug and treatment regimens, most exclude patients with diabetes and examine otherwise healthy individuals.
14
Both the time course of an antifungaldrug and its absolute concentrations within tissues may differ significantly from those observed in the bloodstream.
15
We tested how replicates from diverse strains of Candida albicans, a prevalent human fungal pathogen, evolve in the commonly prescribed antifungaldrug fluconazole.
16
Nearly all of the samples from the 51 patients in facilities in New York City were resistant to fluconazole, a commonly used antifungaldrug.